Kestra Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.39M | Buy |
14,358
+1,148
| +9% | +$511K | 0.03% | 530 |
|
|
2025
Q1 | $6.4M | Sell |
13,210
-3,048
| -19% | -$1.48M | 0.03% | 487 |
|
|
2024
Q4 | $6.55M | Sell |
16,258
-513
| -3% | -$207K | 0.04% | 480 |
|
|
2024
Q3 | $7.8M | Sell |
16,771
-2,973
| -15% | -$1.38M | 0.04% | 444 |
|
|
2024
Q2 | $9.25M | Sell |
19,744
-697
| -3% | -$327K | 0.05% | 386 |
|
|
2024
Q1 | $8.54M | Buy |
20,441
+2,425
| +13% | +$1.01M | 0.06% | 351 |
|
|
2023
Q4 | $7.33M | Buy |
18,016
+2,245
| +14% | +$913K | 0.06% | 338 |
|
|
2023
Q3 | $5.48M | Buy |
15,771
+464
| +3% | +$161K | 0.05% | 363 |
|
|
2023
Q2 | $5.39M | Buy |
15,307
+3,110
| +25% | +$1.09M | 0.05% | 350 |
|
|
2023
Q1 | $3.84M | Sell |
12,197
-9,768
| -44% | -$3.08M | 0.04% | 429 |
|
|
2022
Q4 | $6.34M | Buy |
21,965
+2,761
| +14% | +$797K | 0.06% | 355 |
|
|
2022
Q3 | $5.56M | Sell |
19,204
-2,822
| -13% | -$817K | 0.06% | 346 |
|
|
2022
Q2 | $6.21M | Sell |
22,026
-2,371
| -10% | -$668K | 0.06% | 311 |
|
|
2022
Q1 | $6.37M | Buy |
24,397
+5,720
| +31% | +$1.49M | 0.07% | 312 |
|
|
2021
Q4 | $4.1M | Sell |
18,677
-1,802
| -9% | -$396K | 0.04% | 425 |
|
|
2021
Q3 | $3.72M | Sell |
20,479
-2,320
| -10% | -$421K | 0.04% | 488 |
|
|
2021
Q2 | $4.6M | Sell |
22,799
-948
| -4% | -$191K | 0.05% | 379 |
|
|
2021
Q1 | $5.1M | Buy |
23,747
+18,503
| +353% | +$3.98M | 0.06% | 332 |
|
|
2020
Q4 | $1.22M | Buy |
5,244
+5,158
| +5,998% | +$1.2M | 0.01% | 771 |
|
|
2020
Q3 | $1.45M | Buy |
+86
| New | +$1.45M | 0.03% | 511 |
|